Even in this time of extreme uncertainty, particularly in healthcare, parents are still hearing the words: “your child has cancer” every single day. Cancer doesn’t

While much of the workforce is now working from home, we are excited to partner with IBM research. Folks who want to directly help cc-TDI

While much of the workforce is now working from home, you can join cc-TDI and IBM research! Do you want to directly help cc-TDI develop

We are excited to welcome Dr. Andrew Watson, Ph.D., C.L.P. to the cc-TDI Scientific Advisory Board. Dr. Watson is the Senior Director of the Oregon

Following is an excerpt from Dr. Charles Keller: “For childhood cancer, the potential for giving back childhood in the form of durable cures with minimal

Sometimes our team members are toiling away on behalf of perfect strangers. And sometimes they have a close, personal connection to the work they’re doing.

Hero Up for Children’s Cancer Foundation has funded a pilot research project at cc-TDI to better treat brain tumors that spread in the brain and

We attended and presented at the Third International Pediatric Liver Tumor Conference: Focus on High Risk Liver Cancers hosted by Cincinnati Children’s Hospital. The first

Two board members for the price of one! We were thrilled to recently welcome Tim and Heidi Frank to our Board of Directors. Their lives have been

We are grateful for the community that supports the family of Philomena and the Storm the Heavens Fund. For two years, the Storm the Heavens

Team members Charles, Andy, Greta and Stella were honored to attend the recent Sam Day Foundation “OneDaySamDay” soiree. The event featured a video from our Nanocourse which

We are thrilled to welcome John Grant to our Board of Directors. John’s list of credentials is much too lengthy to cover here, so please

We are excited to have a recent study published that benchmarks discovery compounds that turn off the NF-kB pathway in cancer. This was innovative study because

Congratulations to our team members Cora and Noah whose article on CIC-rearranged sarcomas was published recently in Cold Spring Harbor Laboratory Press Molecular Case Studies

cc-TDI and Champions Oncology share the same goal as every parent, scientist and clinical investigator: To get the right drug to treat the specific type of pediatric

See the details at the link below. 2019 Scientific Director’s report & 2020 plans ahead.

it’s ready for order (but like Baby Yoda will arrive in January …) https://cc-tdi.kindful.com/?campaign=1048320